Patients Cut Off From Cheaper Obesity Drugs as FDA Halts Sales of Copycats

Patients Cut Off From Cheaper Obesity Drugs as FDA Halts Sales of Copycats

U.S. regulators are trying to shut down the industry for compounded weight-loss drugs, which could result in higher costs or suspend treatment for patients.
Trump’s Tariff Threat for Drug imports Poses Big Political Risks

Trump’s Tariff Threat for Drug imports Poses Big Political Risks

Levies on Americans’ daily prescriptions and other medicines could raise costs, spur rationing and lead to shortages of critical drugs.